Project 3 - QUANTITATIVE METHODS RESEARCH PROJECT - Abstract Over the past three decades, there have been great advances in HIV research, especially in diagnostics and treatment. Curing HIV will require further advances, particularly in the development of new agents and methods for evaluating incremental improvements in their contribution to cure. Our proposed Revealing Reservoirs during Rebound (R3) program will use a large battery of new technologies to investigate how HIV persists in and populates reservoirs throughout the body. Such new insights will be crucial in developing strategies aimed at curing HIV. To make maximal use of existing and newly generated data requires parallel advances in quantitative methods; hence, we propose a Quantitative Methods Research Project (RP). This RP will maximize the utility of data and samples collected in the overall program through the development of novel approaches for their analysis.
The aims of our Quantitative Methods RP include:
Aim 1 : Discover biomarkers that can predict viral rebound when antiretroviral therapy (ART) is stopped to help guide future curative strategies.
Aim 2 : Precisely characterize HIV populations in T cell subsets and throughout the body and the impact of treatment interruption and re-initiation on these viral populations.
Aim 3 : Determine immune mechanisms by which HIV populations persist during ART by measuring biological quantities associated with viral rebound dynamics after stopping ART, and HIV population dynamics in cellular subsets and anatomic compartments.
Aim 4 : Create a global host model that uses mechanistic and empiric modeling methods to integrate our observations from viral rebound dynamics, HIV population of T cell subsets and tissues, and immunologic and virologic quantities to better understand the HIV in the body and the factors that sustain HIV persistence during ART and contribute to viral rebound when ART is stopped. The successful completion of these aims will provide the analytical framework to better understand the mechanistic underpinning of how HIV persists in the setting of ART, and what factors may be attractive targets to disrupt this viral persistence.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI131385-04
Application #
9984168
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2017-08-01
Project End
2022-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
4
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of California, San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Dubé, Karine; Gianella, Sara; Concha-Garcia, Susan et al. (2018) Ethical considerations for HIV cure-related research at the end of life. BMC Med Ethics 19:83
Hill, Alison L; Rosenbloom, Daniel I S; Nowak, Martin A et al. (2018) Insight into treatment of HIV infection from viral dynamics models. Immunol Rev 285:9-25
Gianella, Sara; Sonya Haw, J; Blumenthal, Jill et al. (2018) The Importance of Human Immunodeficiency Virus Research for Transgender and Gender-Nonbinary Individuals. Clin Infect Dis 66:1460-1466
Dubé, Karine; Luter, Stuart; Lesnar, Breanne et al. (2018) Use of 'eradication' in HIV cure-related research: a public health debate. BMC Public Health 18:245
Chaillon, Antoine; Gianella, Sara; Lada, Steven M et al. (2018) Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc. J Virol 92:
Burlacu, Ruxandra; Umlauf, Anya; Luca, Anca et al. (2018) Sex-based differences in neurocognitive functioning in HIV-infected young adults. AIDS 32:217-225
Hill, Alison L (2018) Mathematical Models of HIV Latency. Curr Top Microbiol Immunol 417:131-156
Hill, Alison L (2018) Modeling HIV persistence and cure studies. Curr Opin HIV AIDS 13:428-434
Letendre, Scott; Bharti, Ajay; Perez-Valero, Ignacio et al. (2018) Higher Anti-Cytomegalovirus Immunoglobulin G Concentrations Are Associated With Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy. Clin Infect Dis 67:770-777
Lin, Timothy C; Gianella, Sara; Tenenbaum, Tara et al. (2018) A Simple Symptom Score for Acute Human Immunodeficiency Virus Infection in a San Diego Community-Based Screening Program. Clin Infect Dis 67:105-111

Showing the most recent 10 out of 14 publications